Recent studies have reported the effectiveness of BET inhibitors in treating both sensitive and chemoresistant solid tumors, including HNSCC, breast cancer, and colon cancer [23,24,25]. This evidence concerns the gene DNER and head and neck squamous cell carcinoma.